<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03170661</url>
  </required_header>
  <id_info>
    <org_study_id>p17.049</org_study_id>
    <nct_id>NCT03170661</nct_id>
  </id_info>
  <brief_title>Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions.</brief_title>
  <acronym>BLISS 4</acronym>
  <official_title>Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions, Hemodynamics and Postoperative Pain in Patients Undergoing Laparoscopic Retroperitoneal Surgery for Prostatectomy or Nephrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A deep neuromuscular block (NMB) is often associated with improved surgical conditions
      especially in laparoscopic surgery. We previously showed that deep NMB is superior to a
      moderate NMB under propofol anesthesia. However, this may not apply to sevoflurane anesthesia
      and sevoflurane by itself produces some degree of muscle relaxation. We therefore plan to
      investigate the effect of deep NMB on surgical conditions under sevoflurane anesthesia
      maintenance.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Leiden surgical rating scale</measure>
    <time_frame>during surgery</time_frame>
    <description>During the procedure, the surgical condition will be scored by the surgeon using a 5‐point surgical rating scale (1: poor ; 5: optimal)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Surgical Conditions</condition>
  <arm_group>
    <arm_group_label>Moderate neuromuscular block</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will receive moderate neuromuscular block, aimed at 1-2 twitches train of four</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive deep neuromuscular block, aimed at 1-2 twitches post tetanic count</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deep neuromuscular block</intervention_name>
    <description>Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count</description>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <other_name>high dose rocuronium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with renal or prostatic disease who are will undergo an elective
             laparoscopic renal surgical procedure or laparoscopic prostatectomy;

          -  American Society of Anesthesiologists (ASA) class I‐III

          -  &gt; 18 years of age;

          -  Ability to give oral and written informed consent.

        Exclusion Criteria:

          -  Known or suspected neuromuscular disorders impairing neuromuscular function;

          -  Allergies to muscle relaxants, anesthetics or narcotics;

          -  A (family) history of malignant hyperthermia;

          -  Women who are or may be pregnant or are currently breast feeding;

          -  Renal insufficiency, as defined by glomerular filtration rate &lt; 30 ml/h creatinine.

          -  Previous retroperitoneal surgery at the site of the current surgery.

          -  Body mass index &gt; 35 kg/m2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Dahan, MD PhD</last_name>
    <phone>+31 71 526 2301</phone>
    <email>a.dahan@lumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2017</study_first_submitted>
  <study_first_submitted_qc>May 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Albert Dahan</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

